Ivan Rich, Nikolaus Trede, Chris Brodie | GenomeWeb
ImmuneRegen BioSciences announced this week that it has appointed Ivan Rich to its advisory board. The company said that Rich's experience as the founder, chairman, and CEO of HemoGenix, a research laboratory specializing in stem cell applications, is expected to benefit ImmuneRegen as it focuses on research and product development of its drug candidate, the adult stem cell-active compound Homspera.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.